dextrothyroxine has been researched along with Asymptomatic Colonization in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahiskali, A; Shaughnessy, M; Swart, B; Wolf, JM | 1 |
| Al-Wakeel, M; Alsaabi, A; Ayoub, H; Bazzal, AA; Chouman, M; Eid, AH; Fawaz, M; Hajjeh, O; Hassan, H; Mouawia, H; Moussawi, MA; Raad, A; Raad, H; Saab, HB; Salami, A; Samaha, AA | 1 |
| Krolewiecki, A; Nutman, TB | 1 |
| Fujita, J; Higashiarakawa, M; Hirata, T; Hokama, A; Kinjo, T; Naka, H; Parrott, G; Tanaka, T | 1 |
1 review(s) available for dextrothyroxine and Asymptomatic Colonization
| Article | Year |
|---|---|
Strongyloidiasis: A Neglected Tropical Disease.
Topics: Animals; Antiparasitic Agents; Asymptomatic Infections; Clinical Trials as Topic; Disease Management; Humans; Immunoassay; Ivermectin; Molecular Diagnostic Techniques; Neglected Diseases; Soil; Strongyloidiasis | 2019 |
1 trial(s) available for dextrothyroxine and Asymptomatic Colonization
| Article | Year |
|---|---|
Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon.
Topics: Adult; Antiviral Agents; Asymptomatic Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Ivermectin; Lebanon; Male; SARS-CoV-2; Treatment Outcome; Viral Load | 2021 |
2 other study(ies) available for dextrothyroxine and Asymptomatic Colonization
| Article | Year |
|---|---|
Implementation and Outcomes of an Empiric Ivermectin Strongyloides Treatment Protocol for Patients Receiving High-Dose Corticosteroids for Severe COVID-19.
Topics: Adrenal Cortex Hormones; Animals; Asymptomatic Infections; Clinical Protocols; COVID-19; Humans; Inpatients; Ivermectin; Strongyloides stercoralis; Strongyloidiasis | 2023 |
Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.
Topics: Age Factors; Aged; Animals; Antibodies, Helminth; Antinematodal Agents; Asymptomatic Infections; Coinfection; Diagnosis, Differential; Eosinophils; Female; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunoglobulin E; Ivermectin; Leukocyte Count; Male; Middle Aged; Sex Factors; Strongyloides stercoralis; Strongyloidiasis | 2017 |